|
CENPL expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.44979999999284E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.94485999999161E-05 |
| Normal-vs-Stage2 |
1.627220E-04 |
| Normal-vs-Stage3 |
4.484900E-03 |
| Normal-vs-Stage4 |
1.162140E-02 |
| Stage1-vs-Stage2 |
3.507800E-01 |
| Stage1-vs-Stage3 |
4.934400E-01 |
| Stage1-vs-Stage4 |
5.797800E-01 |
| Stage2-vs-Stage3 |
1.861450E-01 |
| Stage2-vs-Stage4 |
2.747800E-01 |
| Stage3-vs-Stage4 |
9.823400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.203840E-04 |
| Normal-vs-AfricanAmerican |
2.195600E-01 |
| Normal-vs-Asian |
7.023900E-04 |
| Caucasian-vs-AfricanAmerican |
1.856360E-01 |
| Caucasian-vs-Asian |
6.025800E-01 |
| AfricanAmerican-vs-Asian |
9.770000E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.818700E-03 |
| Normal-vs-Female |
1.598199999997E-05 |
| Male-vs-Female |
2.690800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.038100E-04 |
| Normal-vs-Age(41-60Yrs) |
3.05729999983129E-07 |
| Normal-vs-Age(61-80Yrs) |
1.361830E-02 |
| Normal-vs-Age(81-100Yrs) |
7.809600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.275700E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.710000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.417900E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.514200E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.075700E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.418410E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.563400E-01 |
| Classical-VS-Follicular |
8.786900E-04 |
| Classical-VS-Other |
2.862400E-01 |
| Classical-VS-Normal |
1.037000E-03 |
| Tall-VS-Follicular |
7.462200E-02 |
| Tall-VS-Other |
4.381600E-01 |
| Tall-VS-Normal |
5.625600E-02 |
| Follicular-VS-Other |
9.707400E-01 |
| Follicular-VS-Normal |
7.88070000035113E-07 |
| Other-VS-Normal |
4.469700E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.11009999995238E-06 |
| Normal-vs-N1 |
2.822600E-03 |
| N0-vs-N1 |
5.073800E-01 |
|
|
